N-(4-Amino-3-methoxyphenyl)methanesulfonamide, 95.0%, 250mg

2-[(DIPHENYLMETHYL)THIO]ACETAMIDE, 97.0%, 1g

7-Bromo-3-methyl-[1,2,4]triazolo[4,3-a]pyridine, 95.0%, 250mg

2-Acetyl-5-cyanothiophene, 98.0%, 250mg

3-Amino-4-bromopyrazole, 97.0%, 5g

Condensador Abbe 1,25 NA con apertura para campo oscuro y corredera de contraste de fases. Sin diapositivas de campo oscuro y sin diapositivas de contraste de fase

6-Amino-5-iodonicotinonitrile, 97.0%, 1g

(3,5-Bis-difluoromethyl-pyrazol-1-yl)-acetic acid, 95.0%, 2g

4,4,4-Trifluoro-1-(o-tolyl)butane-1,3-dione, 95.0%, 25g

1,2-Bis(2,3,4,5,6-pentabromophenyl)ethane>96.0%(T)25g

1-tert-Butyl 3-ethyl 5-oxopiperidine-1,3-dicarboxylate, 95.0%, 250mg

2-Methylpyrrolidine hydrochloride, 97.0%, 5g

(4-(Aminomethyl)-3-methylphenyl)(2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)methanone, 97%, 250mg